farnesol has been researched along with Astrocytoma, Grade IV in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozdağ Pehlivan, S; Buğdaycı, KE; Demir, T; Kaffashi, A; Karlı Oğuz, K; Koşucu, H; Lüle, S; Mut, M; Sarısözen, C; Söylemezoğlu, F; Vural, İ | 1 |
| Bozdağ Pehlivan, S; Gürsoy-Özdemir, Y; Işıkay, I; Kaffashi, A; Kara, A; Lüle, S; Mut, M; Oguz, KK; Öztürk, N; Sekerdag, E; Söylemezoğlu, F; Vural, I; Yavuz, B | 1 |
| Goldshmit, Y; Kloog, Y; Pinkas-Kramarski, R; Trangle, SS | 1 |
| Amariglio, N; Blum, R; Jacob-Hirsch, J; Kloog, Y; Rechavi, G | 1 |
| Amos, S; Hussaini, IM; McPheson, R; Polar, G; Redpath, GT; Schiff, D | 1 |
| Blum, R; Elkon, R; Goldberg, L; Kloog, Y; Nakdimon, I; Rechavi, G; Shamir, R | 1 |
| Blum, R; Jacob-Hirsch, J; Kloog, Y; Rechavi, G | 1 |
7 other study(ies) available for farnesol and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Farnesylthiosalicylic acid-loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Farnesol; Female; Glioblastoma; Lipids; Nanoparticles; Polyethylene Glycols; Polymers; Rats; Rats, Wistar; Salicylates; Treatment Outcome; Tumor Burden | 2017 |
A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles.
Topics: Administration, Intranasal; Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Drug Carriers; Drug Delivery Systems; Farnesol; Female; Glioblastoma; Lipids; Magnetic Resonance Imaging; Nanoparticles; Polyesters; Polyethylene Glycols; Rats; Rats, Wistar; Salicylates; Treatment Outcome | 2017 |
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aptamers, Nucleotide; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Farnesol; Glioblastoma; Humans; Mice, Nude; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; Phosphorylation; ras Proteins; Receptor Cross-Talk; RNA-Binding Proteins; Salicylates; Signal Transduction; Time Factors; Tumor Burden | 2014 |
Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death.
Topics: Cell Death; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Farnesol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Phosphatidylinositol 3-Kinases; ras Proteins; Salicylates; Transcription Factors | 2005 |
Farnesylthiosalicylic acid induces caspase activation and apoptosis in glioblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Farnesol; Glioblastoma; Humans; Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; ras Proteins; Salicylates; Signal Transduction; Time Factors | 2006 |
E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition.
Topics: Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; E2F1 Transcription Factor; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Farnesol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Green Fluorescent Proteins; Humans; Immunoblotting; Immunohistochemistry; Luciferases; Phosphorylation; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; ras Proteins; Recombinant Fusion Proteins; Retinoblastoma Protein; Salicylates | 2006 |
Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Farnesol; Gene Expression; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; ras Proteins; RNA, Messenger; Salicylates; Survivin; Transfection | 2006 |